Literature DB >> 25452121

The role of SIRT1 in cancer: the saga continues.

Melissa J Wilking1, Nihal Ahmad2.   

Abstract

This Commentary highlights the article by Di Sante et al, which presents data supporting the status of SIRT1 as a tumor suppressor in prostate cancer.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25452121      PMCID： PMC4729271          DOI： 10.1016/j.ajpath.2014.10.002

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


  16 in total

Review 1.  The importance of p53 location: nuclear or cytoplasmic zip code?

Authors:  Aurora O'Brate; Paraskevi Giannakakou
Journal:  Drug Resist Updat       Date:  2003-12       Impact factor: 18.500

2.  Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.

Authors:  Wen Yong Chen; David H Wang; Raywhay Chiu Yen; Jianyuan Luo; Wei Gu; Stephen B Baylin
Journal:  Cell       Date:  2005-11-04       Impact factor: 41.582

3.  Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.

Authors:  Masaya Tanno; Jun Sakamoto; Tetsuji Miura; Kazuaki Shimamoto; Yoshiyuki Horio
Journal:  J Biol Chem       Date:  2006-12-30       Impact factor: 5.157

4.  Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria.

Authors:  Gabriele Di Sante; Timothy G Pestell; Mathew C Casimiro; Sara Bisetto; Michael J Powell; Michael P Lisanti; Carlos Cordon-Cardo; Mireia Castillo-Martin; Dennis M Bonal; Valentina Debattisti; Ke Chen; Liping Wang; Xiaohong He; Michael W McBurney; Richard G Pestell
Journal:  Am J Pathol       Date:  2015-01       Impact factor: 4.307

Review 5.  Sirtuin 1 (SIRT1): the misunderstood HDAC.

Authors:  Walter Stünkel; Robert M Campbell
Journal:  J Biomol Screen       Date:  2011-11-15

Review 6.  Nonhistone protein acetylation as cancer therapy targets.

Authors:  Brahma N Singh; Guanghua Zhang; Yi L Hwa; Jinping Li; Sean C Dowdy; Shi-Wen Jiang
Journal:  Expert Rev Anticancer Ther       Date:  2010-06       Impact factor: 4.512

Review 7.  Mammalian sirtuins: biological insights and disease relevance.

Authors:  Marcia C Haigis; David A Sinclair
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

8.  SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.

Authors:  D Herranz; A Maraver; M Cañamero; G Gómez-López; L Inglada-Pérez; M Robledo; E Castelblanco; X Matias-Guiu; M Serrano
Journal:  Oncogene       Date:  2012-09-17       Impact factor: 9.867

9.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

Review 10.  SIRT1, is it a tumor promoter or tumor suppressor?

Authors:  Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580
View more
  10 in total

1.  MiRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1.

Authors:  Hao Fu; Wenke Song; Xuancai Chen; Tao Guo; Bin Duan; Xinxi Wang; Yachun Tang; Liang Huang; Chi Zhang
Journal:  Mol Cell Biochem       Date:  2017-07-17       Impact factor: 3.396

Review 2.  Sirtuins in Skin and Skin Cancers.

Authors:  Liz Mariely Garcia-Peterson; Melissa Jean Wilking-Busch; Mary Ann Ndiaye; Christine Gaby Azer Philippe; Vijayasaradhi Setaluri; Nihal Ahmad
Journal:  Skin Pharmacol Physiol       Date:  2017-07-14       Impact factor: 3.479

3.  NAD metabolism in aging and cancer.

Authors:  John Wr Kincaid; Nathan A Berger
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-05

4.  Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine.

Authors:  Debashri Manna; Rajabrata Bhuyan; Rita Ghosh
Journal:  J Mol Model       Date:  2018-11-17       Impact factor: 1.810

Review 5.  Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy.

Authors:  Yuki Maemoto; Yuki Shimizu; Ryu Katoh; Akihiro Ito
Journal:  J Antibiot (Tokyo)       Date:  2021-08-23       Impact factor: 2.649

6.  CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance.

Authors:  Min Xu; Shiji Fang; Jingjing Song; Minjiang Chen; Qianqian Zhang; Qiaoyou Weng; Xiaoxi Fan; Weiqian Chen; Xulu Wu; Fazong Wu; Jianfei Tu; Zhongwei Zhao; Jiansong Ji
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

7.  Sirtuin 1 Inhibiting Thiocyanates (S1th)-A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases.

Authors:  Nathalie Wössner; Zayan Alhalabi; Jessica González; Sören Swyter; Jin Gan; Karin Schmidtkunz; Lin Zhang; Alejandro Vaquero; Huib Ovaa; Oliver Einsle; Wolfgang Sippl; Manfred Jung
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

Review 8.  Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma.

Authors:  Enakshi Sivasudhan; Neil Blake; Zhi-Liang Lu; Jia Meng; Rong Rong
Journal:  Front Cell Dev Biol       Date:  2021-04-01

9.  CSAG2 is a cancer-specific activator of SIRT1.

Authors:  Xu Yang; Patrick Ryan Potts
Journal:  EMBO Rep       Date:  2020-08-05       Impact factor: 8.807

10.  Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells.

Authors:  Ying Cui; Jiang Li; Fei Zheng; Yongri Ouyang; Xi Chen; Lei Zhang; Yang Chen; Lin Wang; Shijie Mu; Huizhong Zhang
Journal:  Med Sci Monit       Date:  2016-02-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.